Adocia
Identification
Instrument name
ADOCIA
Symbol
ADOC
ISIN code
FR0011184241
Exchange / Market
Euronext
Handelssted
Paris
Products family
Stocks
ICB
Biotechnology
Activity description
Adocia specializes in the research and development of biotherapy products used in tissue regeneration and for treating chronic diseases.
At the end of June 2011, the group had a portfolio of 4 products in clinical development (including two in phase 2; PDGF-BB, for treating diabetic foot ulcers, and HinsBet, quick-acting human insulin for treating diabetes).
Website address
www.adocia.com
Operation
IPO date
man 20/02/2012
IPO type
Initial Public Offering
IPO type
Initial Public offering
Catégorie
IPO
Operation calendar
LISTING DATE: 14/02/2012
TRADING DATE: 20/02/2012
Price range
Indicative price range for the Offer: EUR 13.00 - EUR 15.88 ("The Offering Price")